News ARS Pharmaceuticals Reports the EC’s Approval of Eurneffy (Adrenaline Nasal Spray) to Treat Type I Allergic Reactions ByDipanshu DixitAugust 26, 20240Comments
News Regeneron’s Ordspono (Odronextamab) Receives the EC’s Approval to Treat R/R Follicular Lymphoma and Diffuse Large B-cell Lymphoma ByDipanshu DixitAugust 24, 20240Comments
News Johnson & Johnson’s Balversa (Erdafitinib) Receives the EC’s Approval to Treat Urothelial Carcinoma ByDipanshu DixitAugust 23, 20240Comments
News Moderna’s mRESVIA (mRNA-1345) Vaccine Gains the EC’s Approval to Prevent Lower Respiratory Tract Disease (LTRD) ByDipanshu DixitAugust 23, 20240Comments
INSIGHTS+ Know Your Investor: Arch Venture Partners (August’24 Edition)ByPrince GiriAugust 21, 20240Comments
VIEWPOINTS Advancing Cancer Therapy Delivery: Manojkumar Bupathy from Rocky Mountain Cancer Centers in Conversation with PharmaShotsBySaurabh ChaubeyAugust 20, 20240Comments
THOUGHTSPOT LMSW vs. LCSW: What Are the Differences Between These Jobs?ByAndrea LaceyAugust 20, 20240Comments
News GlycoNex Reports the Completion of P-I Study Assessing SPD8 (Biosimilar, Prolia) for Osteoporosis ByDipanshu DixitAugust 19, 20240Comments
